Allergic State News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Note that some links may require registration or subscription. On the heels of its recently released data in teens ages 12-15, Pfizer and BioNTech said they applied to the FDA to expand emergency use authorization for their COVID-19 vaccine to include that age group. Reuters) Johnson & Johnson's COVID-19 vaccine is in hot water, with the European Medicines Agency announcing an investigation into post-vaccination blood clots. Closer to home, vaccine sites in North Carolina, Colorado and Georgia temporarily shut down administration of the vaccine due to adverse reactions. ( Bloomberg, CBS News)...

Spoiler alert: The vaccines work! ZDoggMD talks about how the new coronavirus vaccines are remarkably safe and effective and why it's about time that the CDC stated the obvious. He also touches on Facebook censorship. Following is a rough transcript of his remarks (Note: errors are possible): ZDoggMD: What's up, everybody? Welcome to the ZDoggMD show. The CDC has basically come out today and said what we've all been thinking for the past few weeks -- meaning the people that I've had on my show -- what I've been saying publicly, which is if you're vaccinated, vaccines are the endpoint of t...

Prasad on pregnant women, grandmas, and how Dr. Fauci has come around

email article The peanut-powder oral treatment Palforzia became the first FDA-approved immunotherapy for food allergy in late January 2020. The peanut (Arachis Hypogaea) allergen powder-dnfp is designed to desensitize peanut allergies in children and adolescents, and prevent potentially life-threatening reactions. Within 6 weeks of its approval for use in children, age 4-17 years, most of the U.S. shut down due to the pandemic, and it was widely agreed that the timing of the immunotherapy's arrival on the U.S. market was less than optimal. A little over a year later, it is still unclear...

No dissent on question of whether benefits outweigh risks